1. Home
  2. VALN vs GCI Comparison

VALN vs GCI Comparison

Compare VALN & GCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • GCI
  • Stock Information
  • Founded
  • VALN 2012
  • GCI 1997
  • Country
  • VALN France
  • GCI United States
  • Employees
  • VALN N/A
  • GCI N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • GCI Newspapers/Magazines
  • Sector
  • VALN Health Care
  • GCI Consumer Discretionary
  • Exchange
  • VALN Nasdaq
  • GCI Nasdaq
  • Market Cap
  • VALN 510.7M
  • GCI 509.6M
  • IPO Year
  • VALN 2021
  • GCI N/A
  • Fundamental
  • Price
  • VALN $6.40
  • GCI $3.55
  • Analyst Decision
  • VALN Strong Buy
  • GCI Buy
  • Analyst Count
  • VALN 3
  • GCI 3
  • Target Price
  • VALN $15.33
  • GCI $5.70
  • AVG Volume (30 Days)
  • VALN 83.3K
  • GCI 1.5M
  • Earning Date
  • VALN 05-07-2025
  • GCI 05-01-2025
  • Dividend Yield
  • VALN N/A
  • GCI N/A
  • EPS Growth
  • VALN N/A
  • GCI N/A
  • EPS
  • VALN N/A
  • GCI 0.36
  • Revenue
  • VALN $201,099,222.00
  • GCI $2,445,127,000.00
  • Revenue This Year
  • VALN $18.74
  • GCI N/A
  • Revenue Next Year
  • VALN $29.26
  • GCI N/A
  • P/E Ratio
  • VALN N/A
  • GCI $9.92
  • Revenue Growth
  • VALN 21.64
  • GCI N/A
  • 52 Week Low
  • VALN $3.62
  • GCI $2.55
  • 52 Week High
  • VALN $9.50
  • GCI $5.93
  • Technical
  • Relative Strength Index (RSI)
  • VALN 48.49
  • GCI 54.94
  • Support Level
  • VALN $6.18
  • GCI $3.31
  • Resistance Level
  • VALN $6.54
  • GCI $3.55
  • Average True Range (ATR)
  • VALN 0.21
  • GCI 0.14
  • MACD
  • VALN 0.01
  • GCI -0.02
  • Stochastic Oscillator
  • VALN 54.35
  • GCI 30.92

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About GCI Gannett Co. Inc.

Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.

Share on Social Networks: